81
Participants
Start Date
March 29, 2016
Primary Completion Date
November 14, 2022
Study Completion Date
April 19, 2023
Tafasitamab
12 mg/kg
Lenalidomide
25 mg
Semmelweis Egyetem I. Sz. Belgyogyaszati Klinika-Semmelweis University, Budapest
National Institute of Oncology Hematological Department, Budapest
ZNA Middelheim dep Klinische studies Hematologie, Antwerp
Centre Hospitalier Universitaire (CHU) de Liege, Liège
DEKK, Belgyogyaszati Klinika, Debrecen
Az Ospedaliera Santa Maria Facolta di Medicina e Chirurgia, Terni
Clinique Universitaire de Mont Godinne, Yvoir
A .O. S. Maria della Misericordia, Perugia
Somogy Megyei Kaposi Mor Oktato Korhaz (Kaposi Mor County Hospital), Kaposvár
AZ Groeninge-Campus Maria's Voorzienigheid, Kortrijk
A.O.U. Citta della Salute e della Scienza di Torino, Torino
Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA z Warmimsko, Olsztyn
Hospital Universitario Fundacion Jimenez Diaz Servicio de Hematologia Unidad de Linformas Oncohealth Institute, Madrid
AOU Maggiore della Cartia, Novara
Hospital Universitario Puerta de Hierro de Majadahonda, Madrid
Hospital Universitario Quiron Salud Madrid, Pozuelo de Alarcón
Charleston Hematology Oncology Associates, Charleston
Complejo Hospitalario de Navarra (CHN), Pamplona
Szpital Wojewodzki Nr 1 im. Fryderyka Chopina w Rzeszowie, Rzeszów
Ist.Ematologia E Oncologia Medica L.E A.Seragnoli Azienda Ospedaliero-Universitaria, Policlinico S.Orsola-Malpighi, Bologna
Hospital Universitario Virgen del Rocio, Hospital de la Mujer Servicio de Hematologia, Seville
Azienda Ospedaliero - Universitaria Policlinico di Modena Dip di Medicina Diagnostica, Clinica e di Sanità Pubblica, Modena
Ohio State University Medical Center, Columbus
Szpital Wojewodzk I w Opolu SP ZOZ Oddzial Hematologii i Onkologii Hematologicznej, Opole
Universitatsklinikum Essen, Abteilung Haematologie, Essen
St. Joseph Mercy Hospital Cancer Care Center, Ypsilanti
Azienda Ospedaliero Universitaria Careggi-S.O.D. Patologia Medica, Florence
Krankenhaus Nordwest GmbH - Institut Fuer Klinisch-Onkologische Forschung (IKF), Frankfurt
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych w Poznaniu im. prof. Ludwika Bierkowskiego, Poznan
CHU De Clermont Ferrand - Hopital Estaing Service Hematologie Clinique Et Thrapie Cellulaire, Clermont-Ferrand
Centre Hospitalier Lyon-Sud (CHLS), Lyon
Azienda Ospedaliera Univerisitaria Policlinico Consorziale Di Bari UOC Ematologia con Trapianto, Bari
Hopital Universitaire Necker Enfants Malades Service de Hematologie Adultes, Paris
Tyler Hematology-Oncology, Tyler
Klinikum Grosshadern-Klinikum Der Ludwig-Maximilian Universitaet Muenchen, Munich
St. Mary's Hospital And Regional Medical Center, Grand Junction
Centre Hospitalier Universitaire (CHU) De Limoges Hopital Dupuytren, Limoges
UCLA - David Geffen School of Medicine, Los Angeles
Cancer Care - Torrance Memorial Physician Network, Redondo Beach
Klinikum Nuernberg Nord Medizinische Klinik 5 Hamatologie, Nuremberg
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield
Central Coast Medical Oncology Corporation, Santa Maria
Universitaetsklinikum Wuerzburg, Würzburg
Norwalk Hospital, Norwalk
University Hospital Olomouc Hematoonkologicka klinika, Olomouc
Tor Vergata University Department Of Hematology, Roma
Pratia MCM Krakow, Krakow
MTZ Clinical Research Sp. z o.o, Warsaw
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Klinika Nowotworow Ukladu Chlonnego Ul., Warsaw
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Warsaw
Hospital Universitari Germans Trias i Pujol (HUGTP), Badalona
Hospital Universitari Vall d'Hebron, Barcelona
Institut Catala D'Oncologia-Hospital Duran Y Reynals, Barcelona
The Royal Bournemouth & Christchurch Hospitals, Bournemouth
Royal Liverpool University Hospital - Liverpool University Hospitals NHS Foundation Trust, Liverpool
Sarah Cannon Research Institute, London
The Newcastle Hospitals NHS Foundation Trust, Newcastle
Lead Sponsor
MorphoSys AG
INDUSTRY